Clinical Trial Update: Lorcaserin for Preventing Weight Gain Among Smokers [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for lorcaserin aimed at preventing weight gain in smokers, spanning Phase 1 and Phase 2, with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tobacco Use Disorder
• Weight Gain

Drugs mentioned

• Lorcaserin (lorcaserin)

Snippet

Sponsor: Mayo Clinic | Conditions: Tobacco Use Disorder, Weight Gain | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-06-06